A phase I study of preoperative (neoadjuvant) chemotherapy with gemcitabine plus nab-paclitaxel for resectable pancreatic cancer

Neoadjuvant chemotherapy (NAC) has become a standard treatment for borderline resectable pancreatic ductal adenocarcinoma (PDAC). The present study examined the maximum tolerated dose of NAC with gemcitabine plus nab-paclitaxel (GnP) in patients with resectable PDAC. Between 2015 and 2019, 39 patien...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Clin Oncol
Hlavní autoři: Tajima, Hidehiro, Makino, Isamu, Gabata, Ryosuke, Okazaki, Mitsuyoshi, Ohbatake, Yoshinao, Shimbashi, Hiroyuki, Nakanuma, Shinich, Saitoh, Hiroto, Shimada, Mari, Yamaguchi, Takahisa, Okamoto, Koichi, Moriyama, Hideki, Kinoshita, Jun, Nakamura, Keishi, Miyashita, Tomoharu, Ninomiya, Itasu, Fushida, Sachio, Ikeda, Hiroko, Ohta, Tetsuo
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2021
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783717/
https://ncbi.nlm.nih.gov/pubmed/33414907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2020.2188
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky